For Researchers: Other Resources for Researchers
Source: National Institute of Allergy and Infectious Diseases
Information for researchers about the services the National Institute of Allergy and Infectious Diseases (NIAID) provides to assist study investigators who are developing therapies for the treatment of HIV infection, coinfections, and microbicides.
http://www.niaid.nih.gov/daids/pdatguide/ctm.htm
Source: Centers for Disease Control and Prevention
An HIV Special Surveillance Report that presents interview data collected during the 2005 pilot cycle of the Centers for Disease Control and Prevention's (CDC's) Medical Monitoring Project (MMP), a nationally representative, population-based surveillance system to assess clinical and behavioral outcomes among HIV-infected people (data were collected from January 2006 through August 2007).
http://www.cdc.gov/hiv/topics/surveillance/resources/reports/pdf/MMP_2005_Report_6.pdf
Source: National Institutes of Health
Link to the ClinicalTrials.gov Protocol Registration System (PRS) login page, where researchers can update their clinical trial records.
https://register.clinicaltrials.gov/#
Source: Centers for Disease Control and Prevention
Guidelines developed by the Centers for Disease Control and Prevention (CDC) with recommendations for data security and confidentiality procedures for researchers working with public health programs funded by CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).
http://www.cdc.gov/nchhstp/programintegration/docs/PCSIDataSecurityGuidelines.pdf
Source: National Institute of Allergy and Infectious Diseases
Webpage of the Division of Acquired Immunodeficiency Syndrome (DAIDS), part of the National Institute of Allergy and Infectious Diseases (NIAID).
http://www.niaid.nih.gov/about/organization/daids/Pages/default.aspx
Source: U.S. Food and Drug Administration
Information for researchers about the U.S. Food and Drug Administration (FDA) Division of Antiviral Products (DAVP) Pre-IND Consultation Program, which allows communication between a sponsor or investigator of a candidate drug and DAVP early in the development of new therapeutics before sufficient data have been accumulated for an investigational new drug (IND) submission.
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/Overview/ucm077776.htm
Source: Office of Extramural Research - National Institutes of Health
Online search of the National Institutes of Health (NIH) Guide for Grants and Contracts, the official publication for NIH medical and behavioral research grant policies, guidelines, and funding opportunities.
http://grants.nih.gov/grants/guide/index.html
Source: National Institutes of Health
Comprehensive plan for all National Institutes of Health (NIH) HIV-related research for fiscal year (FY) 2013, from the Office of AIDS Research (OAR), NIH.
http://www.oar.nih.gov/strategicplan/fy2013/index.asp
Source: U.S. Food and Drug Administration
Recommendations and guidance regarding the special considerations that researchers should consider when conducting clinical studies for preventive HIV vaccines in pediatric populations.
http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm074819.htm
Source: National Institute of Allergy and Infectious Diseases
Database summarizing all known interactions of HIV-1 proteins with host cell proteins, other HIV-1 proteins, or proteins from disease organisms associated with HIV/AIDS.
http://www.ncbi.nlm.nih.gov/RefSeq/HIVInteractions/#
Source: National Institutes of Health
Webpage with links to fact sheets and resources about HIV/AIDS research at the National Institutes of Health (NIH), including research accomplishments and priorities, training opportunities, and partnerships and collaborations.
http://aids2012.oar.nih.gov/factsheets.html
Source: National Institutes of Health
The Office of AIDS Research (OAR) is located within the National Institutes of Health (NIH) Office of the Director. OAR is responsible for the scientific, budgetary, legislative, and policy elements of the NIH HIV/AIDS research program.
http://www.oar.nih.gov/#
Source: Office of Extramural Research - National Institutes of Health
Official website of the National Institutes of Health (NIH) Office of Extramural Research (OER), which provides the leadership, oversight, tools, and guidance needed to administer and manage NIH grants, policies, and operations.
http://grants.nih.gov/grants/oer.htm
Source: National Institute of Allergy and Infectious Diseases
List of National Institute of Allergy and Infectious Diseases (NIAID)-related resources and services for researchers.
http://www.niaid.nih.gov/labsandresources/resources/pages/default.aspx
Source: U.S. Food and Drug Administration
Information on good clinical practices (GCPs), the standard guidelines for the design and implementation of clinical trials. Website provides links to regulations, enforcement information, and educational materials.
http://www.fda.gov/oc/gcp/default.htm
Source: Centers for Disease Control and Prevention
Information about the surveillance systems that the Centers for Disease Control and Prevention (CDC) has developed to collect, analyze, and disseminate data on HIV/AIDS in the United States.
http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/surveillance.htm
Source: Centers for Disease Control and Prevention
Definitions and explanations of the terms used in the Centers for Disease Control and Prevention (CDC) surveillance reports.
http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/surveillance-table.htm
Source: The United States President's Emergency Plan for AIDS Relief
Website of the United States President's Emergency Plan for AIDS Relief (PEPFAR). Includes information on the strategy, budget, and activities of this initiative.
http://www.pepfar.gov######
Find more "For Researchers" information on the National Library of Medicine
HIV/AIDS Portal: